COX-1
28 drugs PainCNSImmunology
9
approved indications
28
Approved Drugs
23
Companies
28
Indications
3
Therapeutic Areas
Top Drugs
Unlock Full Target Intelligence PRO
✓ Competitive landscape by company (23 companies)
✓ All 28 approved drugs
✓ Therapeutic area breakdown
✓ Full indication list (28 indications)
✓ Patent cliff analysis
✓ Clinical trials pipeline
Upgrade to Pro
Starting at $99/mo
Drugs by Company
Pfizer 3 drugs
ATNAHS PHARMA US 2 drugs
Lupin 2 drugs
By Therapeutic Area
Pain 10 drugs
Immunology 9 drugs
Drugs by Company PRO
ATNAHS PHARMA US 2 drugs
Lupin 2 drugs
Sun Pharma 2 drugs
TWI PHARMS 1 drug
Dr. Reddy's 1 drug
MICRO LABS 1 drug
IBSA 1 drug
IBSA INST BIO 1 drug
SOLUBIOMIX 1 drug
+ 13 more companies
By Therapeutic Area
Pain 10 drugs
FLECTOR, CALDOLOR, PONSTEL, OMIDRIA +6 more
Immunology 9 drugs
EC-NAPROSYN, NAPROSYN, NAPRELAN, NAPROXEN AND ESOMEPRAZOLE MAGNESIUM +5 more
Other 6 drugs
LICART, BROMFENAC SODIUM, PROLENSA, BROMSITE +2 more
CNS 3 drugs
SUMATRIPTAN AND NAPROXEN SODIUM, CAMBIA, SYMBRAVO
Indications Treated
InflammationOcular PainAcute PainMigrainePainFeverOsteoarthritisRheumatoid ArthritisAnkylosing SpondylitisJuvenile Idiopathic ArthritisGastric UlcerDuodenal UlcerTendonitisBursitisGoutDysmenorrheaJuvenile Rheumatoid ArthritisCluster HeadacheStrainsSprainsContusionsStrainSprainContusionMiosisPostoperative PainTendinitisPrimary Dysmenorrhea
All Drugs Targeting COX-1
| Drug | Company | Approved | Indications | Therapeutic Area |
|---|---|---|---|---|
| EC-NAPROSYN Top | ATNAHS PHARMA US | 1994 | 9 | Immunology |
| NAPROSYN Top | ATNAHS PHARMA US | 1976 | 9 | Immunology |
| NAPRELAN Top | TWI PHARMS | 1996 | 8 | Immunology |
| NAPROXEN AND ESOMEPRAZOLE MAGNESIUM | Dr. Reddy's | 2020 | 5 | Immunology |
| DICLOFENAC SODIUM AND MISOPROSTOL | MICRO LABS | 2012 | 4 | Immunology |
| ARTHROTEC | Pfizer | 1997 | 4 | Immunology |
| FLECTOR | IBSA | 2007 | 4 | Pain |
| DAYPRO | Pfizer | 1992 | 3 | Immunology |
| LICART | IBSA INST BIO | 2018 | 3 | |
| COXANTO | SOLUBIOMIX | 2023 | 3 | Immunology |
| BROMFENAC SODIUM | Lupin | 2011 | 2 | |
| CALDOLOR | CUMBERLAND PHARMS | 2009 | 2 | Pain |
| FELDENE | Pfizer | 1982 | 2 | Immunology |
| SUMATRIPTAN AND NAPROXEN SODIUM | Sun Pharma | 2018 | 2 | CNS |
| PROLENSA | BAUSCH AND LOMB | 2013 | 2 | |
| PONSTEL | AVION PHARMS | 1967 | 2 | Pain |
| BROMSITE | Sun Pharma | 2016 | 2 | |
| OMIDRIA | RAYNER SURGICAL | 2014 | 2 | Pain |
| CAMBIA | ASSERTIO SPECLTY | 2009 | 2 | CNS |
| COMBOGESIC | AFT PHARMS US | 2023 | 1 | Pain |
| SYMBRAVO | AXSOME | 2025 | 1 | CNS |
| SPRIX | ZYLA | 2010 | 1 | Pain |
| COMBOGESIC IV | Hikma | 2023 | 1 | Pain |
| QAMZOVA | NANJING DELOVA | 2025 | 1 | Pain |
| ZIPSOR | ASIO HOLDINGS | 2009 | 1 | Pain |
| XIFYRM | AZURITY | 2025 | 1 | Pain |
| MELOXICAM | NOVITIUM PHARMA | 2004 | - | |
| MEFENAMIC ACID | Lupin | 2010 | - |